These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 19605405)

  • 21. Dachshund binds p53 to block the growth of lung adenocarcinoma cells.
    Chen K; Wu K; Cai S; Zhang W; Zhou J; Wang J; Ertel A; Li Z; Rui H; Quong A; Lisanti MP; Tozeren A; Tanes C; Addya S; Gormley M; Wang C; McMahon SB; Pestell RG
    Cancer Res; 2013 Jun; 73(11):3262-74. PubMed ID: 23492369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel estrogen receptor-alpha binding sites and estradiol target genes identified by chromatin immunoprecipitation cloning in breast cancer.
    Lin Z; Reierstad S; Huang CC; Bulun SE
    Cancer Res; 2007 May; 67(10):5017-24. PubMed ID: 17510434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ligand-independent activation of estrogen receptor alpha by XBP-1.
    Ding L; Yan J; Zhu J; Zhong H; Lu Q; Wang Z; Huang C; Ye Q
    Nucleic Acids Res; 2003 Sep; 31(18):5266-74. PubMed ID: 12954762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell fate factor DACH1 represses YB-1-mediated oncogenic transcription and translation.
    Wu K; Chen K; Wang C; Jiao X; Wang L; Zhou J; Wang J; Li Z; Addya S; Sorensen PH; Lisanti MP; Quong A; Ertel A; Pestell RG
    Cancer Res; 2014 Feb; 74(3):829-39. PubMed ID: 24335958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcription elongation regulator 1 is a co-integrator of the cell fate determination factor Dachshund homolog 1.
    Zhou J; Liu Y; Zhang W; Popov VM; Wang M; Pattabiraman N; Suñé C; Cvekl A; Wu K; Jiang J; Wang C; Pestell RG
    J Biol Chem; 2010 Dec; 285(51):40342-50. PubMed ID: 20956529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential role of a novel transcriptional coactivator PELP1 in histone H1 displacement in cancer cells.
    Nair SS; Mishra SK; Yang Z; Balasenthil S; Kumar R; Vadlamudi RK
    Cancer Res; 2004 Sep; 64(18):6416-23. PubMed ID: 15374949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The estrogen receptor-interacting protein HPIP increases estrogen-responsive gene expression through activation of MAPK and AKT.
    Wang X; Yang Z; Zhang H; Ding L; Li X; Zhu C; Zheng Y; Ye Q
    Biochim Biophys Acta; 2008 Jun; 1783(6):1220-8. PubMed ID: 18302941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen receptor-dependent regulation of CYP2B6 in human breast cancer cells.
    Lo R; Burgoon L; Macpherson L; Ahmed S; Matthews J
    Biochim Biophys Acta; 2010; 1799(5-6):469-79. PubMed ID: 20079471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SnoN oncoprotein enhances estrogen receptor-α transcriptional activity.
    Band AM; Laiho M
    Cell Signal; 2012 Apr; 24(4):922-30. PubMed ID: 22227247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen negatively regulates epidermal growth factor (EGF)-mediated signal transducer and activator of transcription 5 signaling in human EGF family receptor-overexpressing breast cancer cells.
    Boerner JL; Gibson MA; Fox EM; Posner ED; Parsons SJ; Silva CM; Shupnik MA
    Mol Endocrinol; 2005 Nov; 19(11):2660-70. PubMed ID: 15976008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anacardic acid inhibits estrogen receptor alpha-DNA binding and reduces target gene transcription and breast cancer cell proliferation.
    Schultz DJ; Wickramasinghe NS; Ivanova MM; Isaacs SM; Dougherty SM; Imbert-Fernandez Y; Cunningham AR; Chen C; Klinge CM
    Mol Cancer Ther; 2010 Mar; 9(3):594-605. PubMed ID: 20197399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extranuclear functions of ER impact invasive migration and metastasis by breast cancer cells.
    Chakravarty D; Nair SS; Santhamma B; Nair BC; Wang L; Bandyopadhyay A; Agyin JK; Brann D; Sun LZ; Yeh IT; Lee FY; Tekmal RR; Kumar R; Vadlamudi RK
    Cancer Res; 2010 May; 70(10):4092-101. PubMed ID: 20460518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cell fate determination factor dachshund inhibits androgen receptor signaling and prostate cancer cellular growth.
    Wu K; Katiyar S; Witkiewicz A; Li A; McCue P; Song LN; Tian L; Jin M; Pestell RG
    Cancer Res; 2009 Apr; 69(8):3347-55. PubMed ID: 19351840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A hypersensitive estrogen receptor alpha mutation that alters dynamic protein interactions.
    Herynk MH; Hopp T; Cui Y; Niu A; Corona-Rodriguez A; Fuqua SA
    Breast Cancer Res Treat; 2010 Jul; 122(2):381-93. PubMed ID: 19842032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aryl hydrocarbon receptor-mediated transcription: ligand-dependent recruitment of estrogen receptor alpha to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters.
    Matthews J; Wihlén B; Thomsen J; Gustafsson JA
    Mol Cell Biol; 2005 Jul; 25(13):5317-28. PubMed ID: 15964790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PELP1 is a reader of histone H3 methylation that facilitates oestrogen receptor-alpha target gene activation by regulating lysine demethylase 1 specificity.
    Nair SS; Nair BC; Cortez V; Chakravarty D; Metzger E; Schüle R; Brann DW; Tekmal RR; Vadlamudi RK
    EMBO Rep; 2010 Jun; 11(6):438-44. PubMed ID: 20448663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gli1 promotes cell survival and is predictive of a poor outcome in ERalpha-negative breast cancer.
    Xu L; Kwon YJ; Frolova N; Steg AD; Yuan K; Johnson MR; Grizzle WE; Desmond RA; Frost AR
    Breast Cancer Res Treat; 2010 Aug; 123(1):59-71. PubMed ID: 19902354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deregulation of estrogen receptor coactivator proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor in human endometrial tumors.
    Vadlamudi RK; Balasenthil S; Broaddus RR; Gustafsson JA; Kumar R
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6130-8. PubMed ID: 15579769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Augmentation of estrogen receptor-mediated transcription by steroid and xenobiotic receptor.
    Rokutanda N; Iwasaki T; Odawara H; Nagaoka R; Miyazaki W; Takeshita A; Koibuchi Y; Horiguchi J; Shimokawa N; Iino Y; Morishita Y; Koibuchi N
    Endocrine; 2008 Jun; 33(3):305-16. PubMed ID: 19011999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DACH1 suppresses breast cancer as a negative regulator of CD44.
    Xu H; Yu S; Yuan X; Xiong J; Kuang D; Pestell RG; Wu K
    Sci Rep; 2017 Jun; 7(1):4361. PubMed ID: 28659634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.